FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:450-459 August 18, 1994 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Injection-drug use has become an important risk factor for infection with the human immunodeficiency virus (HIV), and HIV infection has become well established among drug users in North America, Europe, South America, and Southeast Asia^1,2,3. In the United States, approximately 34 percent of all the cases of the acquired immunodeficiency syndrome (AIDS) in adults have occurred either in injection-drug users or in their sexual contacts. The proportion of the AIDS epidemic that is related to injection-drug use has increased steadily over the past decade,^2,3 and it is particularly high among women and ethnic minorities³. In addition, the spectrum . . . [Full Text of this Article]

Screening for and Diagnosis of Substance Abuse

History

Physical Examination

Laboratory Tests

The Spectrum of HIV-Related Diseases in Injection-Drug Users

Bacterial Infections

Tuberculosis

Sexually Transmitted Diseases

Hepatitis

Other Retroviral Infections

Cancer

Revised Case Definition of AIDS

Substance Abuse and the Differential Diagnosis of HIV-Related Symptoms

Constitutional Symptoms

Pulmonary Symptoms

Neurologic Symptoms

Dermatologic and Other Symptoms

Clinical Issues in the Care of Injection-Drug Users with HIV Infection

Preventive Health Care

Referral of Patients for Treatment of Substance Abuse

Drug Interactions

Issues in Women's Health Care

Psychosocial Issues in the Care of Injection-Drug Users with HIV Infection

Access to Care and Compliance with Treatment

Psychiatric Illness and Cognitive Dysfunction

Prescription of Psychoactive Medications

Physician-Patient Interactions

            Potential Conflicts

            Productive Physician-Patient Interactions

Challenges for the Future

Source Information

From the Departments of Medicine (P.G.O., P.A.S.) and Psychiatry (R.S.S.), Yale University School of Medicine, New Haven, Conn.

Address reprint requests to Dr. O'Connor at the Primary Care Center, Yale University School of Medicine, P.O. Box 208025, New Haven, CT 06520-8025.

References

Related Letters:

The Care of Injection-Drug Users with HIV Infection
Newman R. G., Selbovitz L. G., Zide-Selbovitz L., Blansfield H. N., O'Connor P. G., Selwyn P. A., Schottenfeld R. S.
Extract | Full Text  
N Engl J Med 1994; 331:1773-1774, Dec 29, 1994. Correspondence

This article has been cited by other articles:

• Pieper, B., Kirsner, R. S., Templin, T. N., Birk, T. J. (2007). Injection Drug Use: An Understudied Cause of Venous Disease. Arch Dermatol 143: 1305-1309 [Abstract] [Full Text]  
• Stoltz, J.-A., Wood, E., Small, W., Li, K., Tyndall, M., Montaner, J., Kerr, T. (2007). Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health (Oxf) 29: 35-39 [Abstract] [Full Text]  
• Lucas, G. M., Griswold, M., Gebo, K. A., Keruly, J., Chaisson, R. E., Moore, R. D. (2006). Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral Therapy. Am J Epidemiol 163: 412-420 [Abstract] [Full Text]  
• Krantz, M. J., Mehler, P. S. (2004). Treating Opioid Dependence: Growing Implications for Primary Care. Arch Intern Med 164: 277-288 [Abstract] [Full Text]  
• Pakyz, A. L., Newberry, Y., Townsend, G. C. (2003). Human Immunodeficiency Virus Infection: A Focus on Women. Journal of Pharmacy Practice 16: 170-181 [Abstract]  
• Martin-Fernandez, J., Escobar-Rodriguez, I., Campo-Angora, M., Rubio-Garcia, R. (2001). Evaluation of Adherence to Highly Active Antiretroviral Therapy. Arch Intern Med 161: 2739-2740 [Full Text]  
• Edlin, B. R., Seal, K. H., Lorvick, J., Kral, A. H., Ciccarone, D. H., Moore, L. D., Lo, B. (2001). Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?. NEJM 345: 211-214 [Full Text]  
• Samet, J. H., Friedmann, P., Saitz, R. (2001). Benefits of Linking Primary Medical Care and Substance Abuse Services: Patient, Provider, and Societal Perspectives. Arch Intern Med 161: 85-91 [Abstract] [Full Text]  
• Burris, S., Lurie, P., Abrahamson, D., Rich, J. D. (2000). Physician Prescribing of Sterile Injection Equipment To Prevent HIV Infection: Time for Action. ANN INTERN MED 133: 218-226 [Abstract] [Full Text]  
• O'Connor, P. G., Fiellin, D. A. (2000). Pharmacologic Treatment of Heroin-Dependent Patients. ANN INTERN MED 133: 40-54 [Abstract] [Full Text]  
• Berger, A. R., Schaumburg, H. H., Gourevitch, M. N., Freeman, K., Herskovitz, S., Arezzo, J. C. (1999). Prevalence of peripheral neuropathy in injection drug users. Neurology 53: 592-592 [Abstract] [Full Text]  
• CAPITANIO, J. P., HEREK, G. M. (1999). AIDS-Related Stigma and Attitudes toward Injecting Drug users among Black and White Americans. American Behavioral Scientist 42: 1148-1161 [Abstract]  
• Sherer, R. (1998). Adherence and Antiretroviral Therapy in Injection Drug Users. JAMA 280: 567-568 [Full Text]  
• CHITWOOD, D. D., McBRIDE, D. C., METSCH, L. R., COMERFORD, M., McCOY, C. B. (1998). A Comparison of the Need for Health Care and Use of Health Care by Injection-Drug Users, Other Chronic Drug Users, and Nondrug Users. American Behavioral Scientist 41: 1107-1122 [Abstract]  
• O'Connor, P. G., Schottenfeld, R. S. (1998). Patients with Alcohol Problems. NEJM 338: 592-602 [Full Text]  
• Kelleher, P., Cox, S., McKeogh, M. (1997). HIV infection: the spectrum of symptoms and disease in male and female patients attending a London hospice. Palliat Med 11: 152-158 [Abstract]  
• Marder, K., Liu, X., Stern, Y., Malouf, R., Dooneief, G., Bell, K., Todak, G., Joseph, M., Sorrell, S., Sadr, W. E., Williams, J. B. W., Ehrhardt, A., Stein, Z., Gorman, J. (1995). Risk of Human Immunodeficiency Virus Type 1--Related Neurologic Disease in a Cohort of Intravenous Drug Users. Arch Neurol 52: 1174-1182 [Abstract]  
• Czachor, J. S., Gleckman, R. A. (1995). Selective Causes of Fever in Adult Human Immunodeficiency Virus--Infected Patients Relative to CD4+ Cell Counts. Arch Fam Med 4: 879-884 [Abstract]  
• Newman, R. G., Selbovitz, L. G., Zide-Selbovitz, L., Blansfield, H. N., O'Connor, P. G., Selwyn, P. A., Schottenfeld, R. S. (1994). The Care of Injection-Drug Users with HIV Infection. NEJM 331: 1773-1774 [Full Text]